Clinical trial
Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People
NCT00053430 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00053430 |
|---|---|
| Title | Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People |
| Official title | Pharmacologic T Cell Costimulation In HIV Disease |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Thalidomide, Thalidomide placebo |
| Enrollment | 40 |
| Start date | Apr 1, 2001 |
| Primary completion | Aug 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Jan 30, 2003 |
| Last update posted | Aug 7, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: